Exposure to 4-tert-octylphenol accelerates sexual differentiation and disrupts expression of steroidogenic factor 1 in developing bullfrogs. by Mayer, Loretta P et al.
Endocrine-disrupting compounds (EDCs)
are ubiquitous in the environment and have
been documented to have deleterious effects
in many species including humans (1). In
particular, if exposure during development
disrupts endocrine function that is critical to
organogenesis, organ function in the adult
organism may be impaired. For this reason,
an understanding of the effects of EDCs dur-
ing development is critical.
In these studies, we used 4-tert-octylphenol
(OP), a known EDC (2), which has been
reported to disrupt endocrine function in ﬁsh
(3), frogs (4), and rats (5). OP is an alkyl-
phenol ethoxylate widely used in detergents,
emulsifiers, solubilizers, wetting agents, and
dispersants (6,7). OP makes up 15–20% of
the total alkylphenol ethoxylate market.
Furthermore, some alkylphenols are formed
in anaerobic portions of sewer systems (7).
OP has been reported in aquatic environ-
ments at levels of 0.084 ppb or 0.407 ×
10–9M (8). Exposure of wildlife and human
populations to these levels of OP is therefore
possible.
The expression of sexually dimorphic
phenotypes during embryonic development
requires that genetic sexual determination be
translated to phenotype by a cascade of events
that lead to the formation of a testis or ovary.
Depending on the vertebrate group, the ovary
or testis then produces steroid hormones that
direct male or female sexual differentiation
(9). Steroidogenesis is controlled by the
expression of P450 cytochrome hydroxylases
that are regulated by the nuclear transcription
factor SF-1 (10). Because SF-1 is necessary
for appropriate steroid hormone expression,
and consequently sexual development (10),
its disruption may lead to changes in sexual
differentiation patterns and/or altered adult
reproductive function.
Because amphibians have permeable skin
that makes them sensitive to waterborne com-
pounds, they have been used as models in
studies on the effects of EDCs on reproduc-
tion and development (4,11,12). Studies in
Xenopus laevis tadpoles have shown that treat-
ment with OP skewed the sex ratio toward
females (4). In another amphibian study,
DDT congeners prematurely induced adult
female coloration patterns in juvenile
Hyperolius argus (11). Recently the herbicide
atrazine was demonstrated to induce her-
maphroditic gonad development in X. laevis
(12). Taken together, these studies demon-
strate that amphibians are sensitive to expo-
sure to EDCs. Because of the large size of
bullfrog tadpoles and their well-defined pat-
tern of sexual differentiation (13), they pro-
vide an excellent model for determining the
effects of EDC exposure on molecular changes
that may affect sex differentiation processes.
Binding studies in rats have demonstrated
that OP binds the estrogen receptor (ER);
however, the binding affinity is 1,000-fold
less than that of 17β-estradiol (2,14). These
ER binding studies provide evidence for
potential estrogenic effects of OP. In studies
with fetal rat testis, maternal treatment with
OP reduced the expression of cytochrome
P450 17α-hydroxylase/C17-20 lyase, an
enzyme regulated by SF-1 (15). In subse-
quent experiments, maternal OP exposure
reduced SF-1 mRNA expression in male off-
spring, but caused no significant change in
expression in female offspring (5). These data
indicate that SF-1 expression may be influ-
enced by EDC exposure during development.
However, it is unclear what the developmen-
tal consequences of OP exposure will be on
differentiating gonads.
Using bullfrog tadpoles, we found a sexu-
ally dimorphic pattern of SF-1 protein expres-
sion that emerges at the time of gonadal sexual
differentiation (16). In females, the expres-
sion of SF-1 increases just after the formation
of ovaries, and in males SF-1 expression
decreases as the testes develop. The purpose
of this study was to determine whether there
is a critical time during development when
OP exerts a disruptive effect on amphibian
larval sexual differentiation and whether OP
disrupts the pattern of SF-1 expression that
occurs concomitantly with the differentiation
process.
Materials and Methods
Animals and tissue collection. We collected
Rana catesbeiana tadpoles from the U.S. Fish
and Wildlife Service Buenos Aires National
Wildlife Refuge, Pima County, Arizona, in
March and April 1999 in accordance with the
“Guidelines for the Care and Use of
Experimental Animals” of Northern Arizona
University. Animals were transported to the
laboratory in large containers (53 × 41 × 18
cm) in water from the collection site. Once in
the laboratory, the animals were transferred
to glass aquaria containing dechlorinated tap
water. The animal density for each tank was
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hydroxylases, and the expression of many of these enzymes is controlled by the orphan nuclear
receptor, steroidogenic factor-1 (SF-1). In mammals, SF-1 expression is critical for development of
the reproductive axis and adult reproductive function. In the bullfrog Rana catesbeiana, during
sequential stages of development encompassing sexual differentiation, SF-1 protein expression
becomes elevated in ovaries of sexually differentiating females, whereas expression in testes
decreases. We exposed tadpoles to the industrial pollutant octylphenol (OP) for 24 hr before and
during the critical stages of sexual differentiation to determine whether this known endocrine dis-
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20 animals/10 L. They were fed commercial
fish food (Tetra Min; Pfizer Inc., Morris
Plains, NJ) twice a week. The ﬁsh-food ingre-
dients did not contain any known EDCs per
the manufacturer’s product information.
After a 2-week acclimation period, tadpoles
were staged as described below and placed in
individual glass containers containing 500 mL
of dechlorinated tap water. Using a random
number generator, we assigned animals an
individual number which was placed on the
individual glass container and recorded. For
all studies, the room was maintained at 25 ±
4°C with 12 hr:12 hr light:dark cycle. The
water temperature was 21.9 ± 3.5°C. The pH
for all aquaria and individual containers was
6.0–6.5, monitored daily using pH test strips.
Testicular tissue collected from C57/BL6
adult mice (Harlan, St. Louis, MO) was snap-
frozen in liquid nitrogen and stored at –80°C
until protein extraction for use as reference
standards in the Western blots.
Animal staging. Tadpoles were staged
according to Gosner (13). Specifically, at
stage 32, the hindlimb bud has begun to
show the early signs of differentiation of one
toe. By stage 36, all ﬁve toes are notable, but
not fully developed. These stages match those
described by Swingle (17) as the time before,
during, and just after sex differentiation.
Treatment of staged animals with octyl-
phenol. Twelve animals from each Gosner
stage, 32–36, received 1 of 5 treatments of
either 0, 10–9, 10–8, or 10–7 M OP, resulting
in a total of 240 animals (12 animals/stage/
treatment). A 1-M stock solution of OP
(Aldrich, Milwaukee, WI) in 100% ethanol
(Fisher Scientific, Pittsburgh, PA) was pre-
pared and stored at –20°C in brown glass
until use. The control solution consisted of
100% ethanol stored in an identical manner.
We prepared dilutions of the 1 M OP stock
solution in ethanol daily, before treatment,
and then delivered it into individual bowls
with 500 mL dechlorinated tap water such
that the final concentration of OP was as
listed above. The final concentration of
ethanol in all treatments including controls
was 4.0 × 106 M. We selected a range of doses
that include the dose at which feminization in
males has been observed in the amphibian
X. laevis (4). Because we were looking for sub-
tle changes that may result from exposure to
OP, we did not use any dose that had been
reported to have toxic or lethal effects (18).
We treated animals in groups of 12/hr, 3
groups per day, to maintain constancy of
treatment exposure across all treatment
groups. To minimize the effects of circadian
rhythms, each group of 12 was started on the
hour beginning at 0800 hr. Therefore, the last
of the three groups each day was initiated at
1000 hr. Before treatment, animals were
selected at random and staged as described
previously, placed individually in one of the
five treatment solutions selected at random,
with treatment and time recorded for each
individual. The glass bowls were placed ran-
domly on the animal rack. All animals were
dosed by immersion in the test solution for
24 hr and then killed by immersion in
methanesulfonate-222 (0.1%). No animals
died during the course of OP dosing. Once
killed, animals were then staged, weighed, and
one gonad from each animal was harvested for
histological analysis, weighed, and placed in
tissue-freezing medium (Fisher Scientific).
The contralateral gonad was harvested,
weighed, and snap-frozen in liquid nitrogen
for protein extraction and SF-1 protein quan-
tiﬁcation. During the 24-hr treatment period
we observed no change in the Gosner stage of
development for any individual.
Histology. We sectioned embedded frozen
tissue at 18 µm in a cryostat and thaw-
mounted the tissue to Superfrost slides (Fisher
Scientific). Slides were fixed in cold acetone
for 30 sec, washed in phosphate-buffered
saline (137 mM NaCl, 2.68 mM KCl, 1.47
mM KH2PO4, 8.1 mM Na2HPO4, pH 7.4),
and stained with Mayer’s hematoxylin and
counterstained in 1% eosin (19). We exam-
ined individual sections of gonadal tissue to
establish sexual phenotype based on morpho-
logical criteria (17). Animals were determined
to be female if there was an observable ovarian
vesicle and if large follicles and oocytes were
distinguishable. We identified males by the
presence of a large medullary region and no
distinguishable cortical area and by the densely
packed cells. Undifferentiated gonads were
characterized by a solid structure with a visi-
ble cortex and medulla and no other female
or male characteristics. Sexes were determined
without the observer knowing the treatment
of the individual. In some treatment groups,
some of the 12 gonadal tissues did not pro-
vide clear enough histology to determine the
sex of the individual. We dropped these ani-
mals from the overall analysis for both the
Western blot SF-1 determination and sex
ratios. Therefore, the ﬁnal n value/treatment
is sometimes less than 12.
Immunoprecipitation and Western blots.
Frozen tissue was lysed in an ice-cold buffer
containing 1% Triton-X-100, 150 mM NaCl,
10% glycerol, 0.1% SDS (Fisher Scientific),
50 mM 2 hydroxyethylpiperazine-N´-2-
ethanesulfonic acid (HEPES; Biowhittaker,
Walkersville, MD), 50 mM NaF, 2 mM
EDTA, 1 mM phenylmethylsulfonylﬂuoride,
10 µg/mL leupeptin, 10 µg/mL aprotinin, and
1 mM activated sodium orthovanadate (Sigma,
St. Louis, MO). Samples were homogenized
for 30 sec in 500 µL lysis buffer per gonad and
incubated at 4°C for 30 min. Samples were
then centrifuged at 10,000 × g for 15 min at
4°C. Supernatants were removed, spun again
for 15 min at 4°C at 10,000 × g, and the ﬁnal
supernatants were stored at –20°C. We deter-
mined total protein using the commercial
CBQCA protein assay (Molecular Probes,
Temecula, CA) using bovine serum albumin
as the standard.
The entire sample volume was then
diluted to a total protein concentration of 1
mg/mL in phosphate-buffered saline and
incubated with 35 µL of a 50% slurry of pro-
tein A agarose beads (Pierce, Rockford, IL) in
phosphate-buffered saline and rocked at 4°C
for 10 min to preclear the samples of endoge-
nous immunoglobulin. Samples were then
spun at 14,000 × g for 10 min at 4°C.
Supernatants were removed and brought up
to 500 µL with the tissue lysis buffer and
incubated rocking overnight at 4°C with 5 µg
rabbit anti-mouse SF-1 (Upstate Biotech,
Lake Placid, NY) per 0.5–1.0 mg sample total
protein. Immunocomplexes were bound to
phosphate-buffered saline–washed protein A
agarose beads at 4°C for 10 min, pulse spun,
supernatant was removed, and the complex
was resuspended in 60 µL Laemmli sample
buffer (nonreducing; 125 mM Tris pH 6.8,
4% SDS, 20% glycerol, and 0.0025% bro-
mophenol blue). We used nonreducing
conditions in the sodium dodecylsulfate poly-
acrylamide gel electrophoresis (SDS-PAGE)
to ensure there was no antibody heavy-chain
contamination from the immunoprecipita-
tion step. Complexes were then boiled for
5 min and the beads removed by pulse cen-
trifugation per manufacturer’s directions
(Pierce). We again determined total protein as
previously described, and 20 µg of protein
from each supernatant sample was separated
on SDS-PAGE, using a 10% gel at 240 V and
40 mA of constant current for 105 min and
transferred electrophoretically to nitrocellu-
lose membranes. Immunoblots were probed
with rabbit anti-mouse SF-1 at a dilution of
1:2,500 (Upstate Biotech, NY). The ﬁrst anti-
body was detected with an alkaline-phos-
phatase conjugated goat anti-rabbit antibody
at 1:10,000 (Pierce) and visualized with
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Figure 1. Effects of OP treatment on sexual differ-
entiation by stage was determined by histological
analysis (n = 9–12 per group). The total percentage
of differentiation includes both male and female
individuals. Groups with different letters denote
statistically signiﬁcant differences (p < 0.05).
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bbbSupersignal, a chemiluminescent substrate
(Pierce). We prepared mouse testis reference
protein the same as frog tissue, and one lane
on each gel contained 20 µg of mouse testis
reference protein.
Analysis and quantification of SF-1. To
quantitate SF-1 protein expression in the
developing frog gonads, we first determined
the minimum amount of protein necessary to
detect SF-1 in the smallest gonadal sample
(16). Densitometric analysis for each film
image of the individual immunoblots was per-
formed using the Eagle Eye II computerized
digital camera and Eagle Sight 3.0 software
(Stratagene, La Jolla, CA). We determined
individual intensity values used to reﬂect SF-1
expression by using a ratio of the sample
intensity to an intensity from the mouse testis
reference standard. All samples were then nor-
malized to total gonadal protein for each sam-
ple as reported in arbitrary integrated density
units (IDU). We analyzed 240 samples on 18
separate gels. The mouse testis standard was
randomly placed on each gel to avoid any lane
effect; the intergel variability was 8.8%.
Statistical analysis. To determine statisti-
cally signiﬁcant differences among treatment
groups compared to controls for the percent-
age of the total population that had sexually
differentiated, we constructed contingency
tables and used Fisher’s exact test to make
comparisons between individual treatments
and controls. In the analyses of sex, we com-
pared the observed percentages of females to
males in each treatment group at each stage to
the expected percentages as observed in con-
trols for the given stage. To determine signiﬁ-
cant differences in sex differentiation by stage
with treatment, we used a binomial test.
Before testing for any signiﬁcant differences in
SF-1 expression among treatments by stage,
we tested for homogeneity of variance with an
Fmax test with p = 0.01. For those groups
where the variances were not heterogeneous,
we transformed the data using a log10 transfor-
mation. SF-1 expression data were tested for
normality and homoscedasticity. Differences
in SF-1 expression within sex across stages
were determined by separate one-way analysis
of variance (ANOVA) for each sex. When
data showed a significant effect, we further
analyzed data using a Tukey-Kramer post hoc
pairwise analysis with the signiﬁcance for the
test set at p = 0.05. To determine differences
by treatment for each sex within stages, we
used a two-way ANOVA with sex and treat-
ment as the response variables. Analysis of the
effects of treatment on total animal weight for
each stage was performed using a one-way
ANOVA for each individual stage.
Results
Effect of OP on timing and outcome of sexual
differentiation. We previously observed
almost complete sexual differentiation of the
gonads in both sexes in bullfrogs by Gosner
stage 35 (13,16). Here we examined tissues
from stages 32–36 for sexually distinct
gonadal morphology (Figure 1). For control
animals, primary sexual differentiation was
not observed at stage 32 (n = 9), but the per-
centage of animals differentiated in controls
increased until all animals had either distinct
ovaries or testes by stage 36 (Figure 1).
For all OP treatment groups in stages
32–34, a greater percentage of individuals
underwent gonadal differentiation than did
controls (Figure 1). For animals at stages 35
and 36 differentiation was essentially com-
plete for control and OP-treated animals
(Figure 1). These results suggest that OP
advanced the stage at which the bipotential
gonad differentiates into a morphologically
distinct ovary or testis.
We determined whether both females and
males had accelerated sexual differentiation as
a result of OP treatment and whether OP
treatment induced a change in the expected
50:50 sex ratio (Figure 2A). At stage 32, at
each OP dose there was a signiﬁcant increase
in the percentage of female tadpoles (n =
9–12, p < 0.05) compared to control tad-
poles. At stage 32, there was also a signiﬁcant
increase in percentage of male sexual differen-
tiation relative to controls (n = 9–12, p <
0.05) for each dose. At stage 33 (Figure 2B),
only male differentiation was signiﬁcantly dif-
ferent from controls (n = 11–12, p < 0.05).
However, by stage 33 many females in the
controls had already differentiated. Similar
results are seen for animals treated at stage 34
(Figure 2C; n = 10–11, p < 0.05). At stages
35 and 36 (data not shown), all control and
treatment animals were differentiated. Sex
ratios of OP-treated animals did not differ
from controls at any dose (data not shown).
Changes in SF-1 expression as a result of
OP treatment in differentiating gonads of
bullfrog tadpoles. During sexual differentiation
in the bullfrog there is a sexually dimorphic
expression of SF-1. Relative to undifferentiated
bullfrogs there are elevated levels in females but
significantly lower levels in males starting at
stage 34 (16). We investigated the effect of OP
treatment on SF-1 gonadal expression during
development. In the control groups we found
the same expression pattern of SF-1 that we
observed previously: SF-1 protein levels were
significantly different between females and
males beginning at stage 34 (Figure 3; between
males and females at the 0 dose across all
graphs; ANOVA, n = 9–11, p = 0.0192, F =
6.56). At stage 32, there were no significant
differences in SF-1 expression among the OP
treatment groups (Figure 3A). Because there
was no observable sexual differentiation in the
controls, the data labeled “males + undifferen-
tiated” represents 100% of the sample size. At
stage 33 there was a signiﬁcant increase in SF-1
expression in the ovaries of 10–8-M–treated
females relative to the males (Figure 3B;
ANOVA, n = 9, p = 0.0473, F = 5.16). In the
male treatment groups of stage 34, there was a
signiﬁcant difference in the high dose (10–7 M)
group compared to other treatment groups
(Figure 3C; ANOVA, n = 12, p = 0.044, F =
4.31). In stages 35 and 36 there were no signif-
icant differences between sexes among treat-
ment groups within each stage (Figure 3D,E).
For all OP treatment groups at all stages, there
was no difference in SF-1 protein levels
between sexes. For each of the OP treatment
groups and for all stages, there was no animal
loss, nor was there a significant effect of OP
treatment on whole animal weight (data not
shown).
Discussion
The purpose of this study was to determine the
effects of the endocrine disrupter OP on gona-
dal differentiation in bullfrogs and to determine
whether there was any detectable disruption in
the gonadal expression of SF-1 during this
Articles | Effects of octylphenol on sex differentiation in frogs
Environmental Health Perspectives • VOLUME 111 | NUMBER 4 | April 2003 559
Figure 2. The effects of OP treatment on differentiating females and/or males was determined by histological analysis. Gonads from 0, 10–9, 10–8, or 10–7 M
OP-treated tadpoles were analyzed to determine sex of differentiated individuals in Gosner stages (A) 32, (B) 33, and (C) 34, where percentage of sexual differentia-
tion was signiﬁcantly different from controls. 
*Groups that are signiﬁcantly different from controls within each sex by stage (n = 9–12 per group, p < 0.05).
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previous work, in control groups we saw stage-
dependent gonadal differentiation. This is also
consistent with previous studies in bullfrog in
our laboratory (16) and in laboratories of other
investigators (20). These data indicate that
there is a potential critical period (stage 32–34)
when gonadal differentiation occurs and may
be sensitive to disruption by OP.
Treatment with OP accelerated bullfrog
gonadal differentiation in both females and
males. We observed acceleration at every
Gosner stage and at every OP dose, 10–9 M,
10–8 M, and 10–7 M. The lowest OP dose, 10–9
M, is an environmentally relevant concentra-
tion that is similar to that detected in aquatic
environments of 0.4 x 10–9 M (8). As we had
observed previously, gonadal differentiation in
control animals occurs at an earlier stage in
females than males (16). OP treatment accel-
erated gonadal differentiation in both females
and males such that each differentiated at ear-
lier developmental stages. OP-mediated male
acceleration resulted in gonadal differentiation
that occurred three stages earlier than is
observed in controls. Female OP-mediated
acceleration of gonadal differentiation
occurred at least one stage earlier. Because we
did not treat animals before stage 32 of devel-
opment, we do not know what accelerating
effects OP treatment may have during these
earlier developmental periods. Although this is
the ﬁrst report of acceleration of gonadal dif-
ferentiation in any species due to OP treat-
ment, other studies have demonstrated that in
rats OP treatment in utero accelerates vaginal
opening (21).
There was no change in sex ratio, as the
expected 50:50 distribution of females to
males occurred with and without OP treat-
ment. Kloas et al. (4) found in another
amphibian species, X. laevis, that 10–8 M OP
significantly skews the sex ratio toward
females. However, in that study, animals were
treated for 12 weeks instead of 1 day as in our
study, suggesting that longer-term exposure
to OP in R. catesbeiana tadpoles may result in
not only accelerated differentiation (not
examined in the Kloas et al. study), but also
gonadal feminization.
OP has estrogen-like activity, as evidenced
by estrogen receptor-binding studies in rats
(14) and frogs (22). OP treatment may have
accelerated female bullfrog gonadal differentia-
tion in our studies due to its estrogenic activity.
Female bullfrog ovaries are secreting estradiol
by stage 35 (23), and sexual development of
amphibians is sensitive to estrogen; Treatments
with estradiol can shift sex ratios to 100%
female in X. laevis (4,24,25), but treatment
with estradiol masculinizes already differenti-
ated female tadpole ovaries (24). Furthermore,
blocking 3-β hydroxysteroid dehydrogenase
activity with cyptoterone throughout the dif-
ferentiation process leads to masculinazation of
the gonad (26). However, there are no reports
of estradiol or other steroid treatment acceler-
ating bullfrog gonadal differentiation as we
found here, and we do not yet know if the
change in SF-1 expression we found plays a
role in this acceleration. Future studies in our
laboratory will begin to sort out the interac-
tions among OP, the estrogen receptor, and
SF-1 expression. It is unclear whether OP is
accelerating differentiation via a pathway that
involves binding to estrogen receptors or
through a different molecular mechanism.
SF-1 is required for gonadal development
in mice (27), but the role of SF-1 in bullfrog
sexual differentiation has not been delineated.
In bullfrogs, SF-1 expression is dimorphic
during sexual differentiation (16). As bull-
frogs develop, SF-1 expression increases in
females after they differentiate, but it
decreases in males just before differentiation.
These results suggests that a decline in SF-1
may be necessary for male testicular differen-
tiation, a ﬁnding that merits further investiga-
tion. However, if SF-1 were directly involved
in the control and/or regulation of sexual dif-
ferentiation, we might predict that in the
groups where OP treatment accelerated sexual
differentiation, SF-1 levels should have
decreased in males at earlier stages than in
controls. Instead, although OP induced tes-
ticular development in some males by stage
33, SF-1 levels remained comparable to con-
trols. The same result is seen in males that
were treated at any stage. These results suggest
that SF-1 may not play a direct role in testicu-
lar differentiation in this species. We also
found that within stages, the sexually dimor-
phic expression of SF-1 in stage 34–36 control
animals was disrupted by OP treatment.
Although the outcome of the gonadal sex did
not appear to be affected by these relatively
rapid changes in SF-1 protein expression, the
long-term affects of this disrupted pattern of
SF-1 availability might lead to later anomalies
in amphibian reproductive development.
Interestingly, exposure to OP in mice also
leads to disrupted SF-1 expression (28), and
Articles | Mayer et al.
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Figure 3. Effects of OP treatment on gonadal SF-1 expression (IDU) was determined for each treatment
group. (A) Stage 32; (B) stage 33; (C) stage 34; (D) stage 35; (E) stage 36. Means with different letters
denote statistical signiﬁcance. Within a stage group, across all samples, a and b denote statistical signiﬁ-
cance (two-way ANOVA main effect, n = 9–11 per stage, p = 0.0192, F = 6.56); within a stage by sex. Within
a sex, across treatment groups, x and y denote statistical signiﬁcance (two-way ANOVA main effect, n =
5–7 per group, p = 0.0436, F = 4.31).
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Males + undifferentiatedin rats, offspring of females exposed to OP
exhibit changes in gonadal morphology and
adult reproductive behavior function (29).
Our studies have shown that low-level
doses of OP are sufficient to accelerate the
onset of sexual differentiation. Also, OP treat-
ment disrupted the sexually dimorphic expres-
sion of SF-1 without affecting the outcome of
gonadal differentiation with regard to sex.
Together, the OP-mediated alterations of
gonadal differentiation may have significant
effects on bullfrog reproduction. An abnor-
mality in the timing of sexual differentiation
and/or SF-1 expression could have a detrimen-
tal effect on sexual maturation and, ultimately,
on the success of adult reproduction.
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